Tarragô, Andréa Monteiro Pereira, Grenda Leite Victória, Flamir da Silva Marie, Adriana Malheiro Alle Victória, Marilú Barbieri Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the Amazon <div><p>Abstract Hepatitis C is a worldwide endemic disease. However, hepatitis C virus genotype 4 (HCV GT-4) has rarely been reported in Brazil. HCV GT-4 demonstrates high sustained virological response (SVR). Here, we report the case of a 62-year-old HCV GT-4 positive woman complaining of a headache, nausea, and arthralgia. The patient was treated according to the protocol for genotype 4 (12 weeks administration of 400mg sofosbuvir and 60mg daclatasvir daily) and achieved SVR. Although this is not an Amazonas autochthonous case, the presence of genotype 4 is rarely reported in the region.</p></div> Hepatitis C;Genotype 4;Sustained viral response 2018-01-17
    https://scielo.figshare.com/articles/dataset/Sofosbuvir_and_daclatasvir_combination_therapy_for_current_hepatitis_C_virus_genotype_4_achieves_SVR_a_case_report_of_HCV_genotype_4_from_the_Amazon/5792652
10.6084/m9.figshare.5792652.v1